Products
Online Inquiry
GSK3-IN-1
Cat. No.:
OB0225WX-2155
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
GSK3-IN-1 is a small molecule inhibitor specifically designed to target the glycogen synthase kinase-3 beta (GSK3B) enzyme.
Synonym:
478482-74-5; GSK3-IN-1; 2-((2-Chlorobenzyl)thio)-5-(pyridin-4-yl)-1,3,4-oxadiazole; 2-chlorobenzyl 5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl sulfide; 2-[(2-chlorophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole; 4-(5-{[(2-chlorophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridine; 4-[5-(2-Chloro-benzylsulfanyl)-[1,3,4]oxadiazol-2-yl]-pyridine; 4-{5-[(2-chlorobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine; 2-{[(2-chlorophenyl)methyl]sulfanyl}-5-(pyridin-4-yl)-1,3,4-oxadiazole
CAS No.:
478482-74-5
Compound CID:
851256
Formula:
C14H10ClN3OS
Formula Weight:
303.77
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GSK3-IN-1 is used in chemical biology to investigate the potent and dual inhibition of GSK-3 alpha and beta and its impact on the intracellular signaling networks governing cell fate.
Library Information
Target:
GSK-3
Receptor:
GSK-3β
Pathways:
Stem cells; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-28
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 197.52 mM





